Procalcitonin as a useful marker to decide upon intervention for urinary tract infection
Authors Sugimoto K, Shimizu N, Matsumura N, Oki T, Nose K, Nishioka T, Uemura H
Received 24 April 2013
Accepted for publication 4 June 2013
Published 7 August 2013 Volume 2013:6 Pages 83—86
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 4
Koichi Sugimoto,1,2 Nobutaka Shimizu,1 Naoki Matsumura,2 Takashi Oki,2 Kazuhiro Nose,2 Tsukasa Nishioka,2 Hirotsugu Uemura1
1Department of Urology, Kinki University Faculty of Medicine, Osaka-Sayama, 2Department of Urology, Sakai Hospital, Kinki University Faculty of Medicine, Sakai, Osaka, Japan
Background: Because the use of procalcitonin has been advocated as a marker of bacterial infection, this study was carried out to determine the usefulness of serum PCT as an early marker to decide upon intervention for urinary tract infection.
Methods: The subjects were 68 patients with urinary tract infection (UTI) in whom we measured serum procalcitonin concentration at the start of treatment.
Results: There were 47 patients with nonobstructed UTI and 21 with obstructed UTI. All patients with obstructed UTI were subjected to intervention. There were significant differences in procalcitonin, white blood cells, and creatinine levels between patients with nonobstructed and obstructed UTI (P < 0.05).
Conclusion: Although this retrospective study comprised a small number of patients, we found that procalcitonin was a useful marker to decide upon urinary intervention.
Keywords: procalcitonin, intervention, urinary tract infection, urology
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]